Platinum Biologics highlights stronger compliance standards, responsible innovation, and leadership in the evolving biotech ...
Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...
The American Biotech Innovation Alliance launches to unify domestic strategy amid global competition
A cross-section of biotech leaders is launching the American Biotech Innovation Alliance (ABIA) with the goal of uniting ...
For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just playing out in the lab—it's being shaped by ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The expanded team brings decades of experience spanning biotechnology, AI, and commercialization–advancing Salt AI’s mission to help translational scientists and drug developers accelerate discovery ...
Investor's Business Daily on MSN
Why these four biotech stocks prove that follow-on entries still pop up in stock market leaders
AnaptysBio recorded $234 million in sales over the past four quarters.
Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...
Maher Masoud, CEO of MaxCyte, explains how the current environment is impacting the entrepreneurial spirit in the ...
Zacks Investment Research on MSN
Is First Trust NYSE Arca Biotechnology ETF (FBT) a strong ETF right now?
The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
table { width: 100%; border-collapse: collapse; font-family: Arial, sans-serif; font-size: 14px; } th, td { padding: 8px; text-align: left; } th { background-color ...
Grogan served as assistant to President Trump and director of the Domestic Policy Council 2019-2020. On April 15, President Trump issued an awaited executive order on drug pricing, kicking off a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results